Your browser doesn't support javascript.
loading
[Prevalence and transmission of pyrazinamide-resistant Mycobacterium tuberculosis in Hunan Province,China].
Liu, B B; Hu, P L; Chen, Z H; Yi, S L; Zhang, X P; Tan, Y H.
Afiliación
  • Liu BB; Department of Clinical Laboratory, Hunan Institute for Tuberculosis Control, Hunan Chest Hospital, Changsha 410013, China.
  • Hu PL; Department of Clinical Laboratory, Hunan Institute for Tuberculosis Control, Hunan Chest Hospital, Changsha 410013, China.
  • Chen ZH; Department of Clinical Laboratory, Hunan Institute for Tuberculosis Control, Hunan Chest Hospital, Changsha 410013, China.
  • Yi SL; Department of Clinical Laboratory, Hunan Institute for Tuberculosis Control, Hunan Chest Hospital, Changsha 410013, China.
  • Zhang XP; Department of Clinical Laboratory, Hunan Institute for Tuberculosis Control, Hunan Chest Hospital, Changsha 410013, China.
  • Tan YH; Department of Clinical Laboratory, Hunan Institute for Tuberculosis Control, Hunan Chest Hospital, Changsha 410013, China.
Zhonghua Jie He He Hu Xi Za Zhi ; 45(7): 677-685, 2022 Jul 12.
Article en Zh | MEDLINE | ID: mdl-35768376
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Ganglionar / Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: Zh Revista: Zhonghua Jie He He Hu Xi Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Ganglionar / Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: Zh Revista: Zhonghua Jie He He Hu Xi Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China